110 related articles for article (PubMed ID: 19343308)
1. A novel nonviral gene delivery system: multifunctional envelope-type nano device.
Hatakeyama H; Akita H; Kogure K; Harashima H
Adv Biochem Eng Biotechnol; 2010; 119():197-230. PubMed ID: 19343308
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional envelope-type nano device for non-viral gene delivery: concept and application of Programmed Packaging.
Kogure K; Akita H; Harashima H
J Control Release; 2007 Oct; 122(3):246-51. PubMed ID: 17651856
[TBL] [Abstract][Full Text] [Related]
3. A multifunctional envelope-type nanodevice for use in nanomedicine: concept and applications.
Nakamura T; Akita H; Yamada Y; Hatakeyama H; Harashima H
Acc Chem Res; 2012 Jul; 45(7):1113-21. PubMed ID: 22324902
[TBL] [Abstract][Full Text] [Related]
4. Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid.
Hatakeyama H; Akita H; Kogure K; Oishi M; Nagasaki Y; Kihira Y; Ueno M; Kobayashi H; Kikuchi H; Harashima H
Gene Ther; 2007 Jan; 14(1):68-77. PubMed ID: 16915290
[TBL] [Abstract][Full Text] [Related]
5. Development of lipid particles targeted via sugar-lipid conjugates as novel nuclear gene delivery system.
Masuda T; Akita H; Nishio T; Niikura K; Kogure K; Ijiro K; Harashima H
Biomaterials; 2008 Feb; 29(6):709-23. PubMed ID: 18001828
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional envelope-type nano device (MEND) as a non-viral gene delivery system.
Kogure K; Akita H; Yamada Y; Harashima H
Adv Drug Deliv Rev; 2008 Mar; 60(4-5):559-71. PubMed ID: 18037529
[TBL] [Abstract][Full Text] [Related]
7. Systemic delivery of siRNA to tumors using a lipid nanoparticle containing a tumor-specific cleavable PEG-lipid.
Hatakeyama H; Akita H; Ito E; Hayashi Y; Oishi M; Nagasaki Y; Danev R; Nagayama K; Kaji N; Kikuchi H; Baba Y; Harashima H
Biomaterials; 2011 Jun; 32(18):4306-16. PubMed ID: 21429576
[TBL] [Abstract][Full Text] [Related]
8. [Development of a novel artificial gene delivery system multifunctional envelope-type nano device for gene therapy].
Kogure K
Yakugaku Zasshi; 2007 Oct; 127(10):1685-91. PubMed ID: 17917425
[TBL] [Abstract][Full Text] [Related]
9. Functional improvement of an IRQ-PEG-MEND for delivering genes to the lung.
Ishitsuka T; Akita H; Harashima H
J Control Release; 2011 Aug; 154(1):77-83. PubMed ID: 21619903
[TBL] [Abstract][Full Text] [Related]
10. [Development of various multifunctional envelope-type nano device MEND based on novel assembly technologies].
Kogure K; Akita H; Harashima H
Yakugaku Zasshi; 2008 Feb; 128(2):219-32. PubMed ID: 18239369
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional envelope-type nano device (MEND) for organelle targeting via a stepwise membrane fusion process.
Yamada Y; Akita H; Harashima H
Methods Enzymol; 2012; 509():301-26. PubMed ID: 22568912
[TBL] [Abstract][Full Text] [Related]
12. Enhanced gene expression by a novel stearylated INF7 peptide derivative through fusion independent endosomal escape.
El-Sayed A; Masuda T; Khalil I; Akita H; Harashima H
J Control Release; 2009 Sep; 138(2):160-7. PubMed ID: 19465073
[TBL] [Abstract][Full Text] [Related]
13. A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemma.
Hatakeyama H; Akita H; Harashima H
Adv Drug Deliv Rev; 2011 Mar; 63(3):152-60. PubMed ID: 20840859
[TBL] [Abstract][Full Text] [Related]
14. Octaarginine-modified multifunctional envelope-type nano device for siRNA.
Nakamura Y; Kogure K; Futaki S; Harashima H
J Control Release; 2007 Jun; 119(3):360-7. PubMed ID: 17478000
[TBL] [Abstract][Full Text] [Related]
15. A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo.
Hatakeyama H; Ito E; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
J Control Release; 2009 Oct; 139(2):127-32. PubMed ID: 19540888
[TBL] [Abstract][Full Text] [Related]
16. Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method.
Kogure K; Moriguchi R; Sasaki K; Ueno M; Futaki S; Harashima H
J Control Release; 2004 Aug; 98(2):317-23. PubMed ID: 15262422
[TBL] [Abstract][Full Text] [Related]
17. [Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid].
Hatakeyama H; Akita H; Kogure K; Harashima H
Yakugaku Zasshi; 2007 Oct; 127(10):1549-56. PubMed ID: 17917417
[TBL] [Abstract][Full Text] [Related]
18. "Programmed packaging" for gene delivery.
Hyodo M; Sakurai Y; Akita H; Harashima H
J Control Release; 2014 Nov; 193():316-23. PubMed ID: 24780263
[TBL] [Abstract][Full Text] [Related]
19. Construction of a multifunctional envelope-type nano device by a SUV*-fusion method.
Sasaki K; Kogure K; Chaki S; Kihira Y; Ueno M; Harashima H
Int J Pharm; 2005 May; 296(1-2):142-50. PubMed ID: 15885466
[TBL] [Abstract][Full Text] [Related]
20. [Envelope-type nano device for gene delivery].
Kogure K; Akita H; Harashima H
Nihon Rinsho; 2006 Feb; 64(2):258-62. PubMed ID: 16454179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]